Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam and Propofol for Sedation in Drug-induced Sleep Endoscopy
NCT06784479Phase 4Active, not recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obstructive sleep apnea (OSA) (3 arms). Primary endpoint: Sedation success rate. Started Mar 2025; status: active, not recruiting.
02
Drugs
remimazolam
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06784479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784479.